Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Clinical trial NCT07043894 · RECRUITING

Trial details

NCT number: NCT07043894
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumors Hematological Tumor Children Adolescent Chemotherapy Induced Thrombocytopenia

Start date: 2025-12-25
Primary completion: 2026-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.